Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.

Nigri J, Gironella M, Bressy C, Vila-Navarro E, Roques J, Lac S, Bontemps C, Kozaczyk C, Cros J, Pietrasz D, Mar├ęchal R, Van Laethem JL, Iovanna J, Bachet JB, Folch-Puy E, Tomasini R.

Cell Mol Life Sci. 2017 Nov;74(22):4231-4243. doi: 10.1007/s00018-017-2579-9. Epub 2017 Jun 27.

PMID:
28656348
2.

Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.

Xie MJ, Motoo Y, Iovanna JL, Su SB, Ohtsubo K, Matsubara F, Sawabu N.

Dig Dis Sci. 2003 Mar;48(3):459-64.

PMID:
12757156
3.

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.

Li Q, Wang H, Zogopoulos G, Shao Q, Dong K, Lv F, Nwilati K, Gui XY, Cuggia A, Liu JL, Gao ZH.

Oncotarget. 2016 Nov 22;7(47):77838-77853. doi: 10.18632/oncotarget.12834.

4.

Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer.

Yang YH, Liu JB, Gui Y, Lei LL, Zhang SJ.

World J Gastroenterol. 2017 Oct 28;23(40):7232-7241. doi: 10.3748/wjg.v23.i40.7232.

5.

SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer.

Wang J, Zhou H, Han Y, Liu X, Wang M, Wang X, Yin G, Li X, Xiang M.

J Mol Med (Berl). 2014 Dec;92(12):1257-69. doi: 10.1007/s00109-014-1184-8. Epub 2014 Jul 5.

PMID:
24996521
6.

REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.

Liu X, Wang J, Wang H, Yin G, Liu Y, Lei X, Xiang M.

Cancer Lett. 2015 Jun 28;362(1):45-60. doi: 10.1016/j.canlet.2015.03.014. Epub 2015 Mar 14.

PMID:
25779676
7.

Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.

Ye Y, Xiao L, Wang SJ, Yue W, Yin QS, Sun MY, Xia W, Shao ZY, Zhang H.

Oncotarget. 2016 Jan 26;7(4):3921-33. doi: 10.18632/oncotarget.6473.

8.

Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.

Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.

World J Gastroenterol. 2015 Aug 21;21(31):9348-57. doi: 10.3748/wjg.v21.i31.9348.

9.

Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.

Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R, Hermanova M.

J Gastrointestin Liver Dis. 2011 Dec;20(4):389-96.

10.

Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.

Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Am J Surg Pathol. 2012 Mar;36(3):409-17. doi: 10.1097/PAS.0b013e31824104c5.

11.

Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.

Li W, Liu L, Liu D, Jin S, Yang Y, Tang W, Gong L.

Biochem Biophys Res Commun. 2016 Mar 25;472(1):156-62. doi: 10.1016/j.bbrc.2016.02.087. Epub 2016 Feb 23.

PMID:
26915801
12.

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, Chan DW, Canto M, Lillemoe KD, Cameron JL, Yeo CJ, Hruban RH, Goggins M.

Cancer Res. 2002 Mar 15;62(6):1868-75.

13.

Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.

Xu Q, Fu R, Yin G, Liu X, Liu Y, Xiang M.

Gene. 2016 Mar 10;578(2):263-73. doi: 10.1016/j.gene.2015.12.039. Epub 2015 Dec 21.

PMID:
26719042
14.

Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer.

Li X, Wang Z, Ma Q, Xu Q, Liu H, Duan W, Lei J, Ma J, Wang X, Lv S, Han L, Li W, Guo J, Guo K, Zhang D, Wu E, Xie K.

Clin Cancer Res. 2014 Aug 15;20(16):4326-38. doi: 10.1158/1078-0432.CCR-13-3426. Epub 2014 Jun 19.

15.

MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma.

Chen DW, Fan YF, Li J, Jiang XX.

Tumour Biol. 2013 Jun;34(3):1553-7. doi: 10.1007/s13277-013-0685-3. Epub 2013 Feb 12.

PMID:
23400716
16.

Upregulation of integrin ╬▓4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.

Masugi Y, Yamazaki K, Emoto K, Effendi K, Tsujikawa H, Kitago M, Itano O, Kitagawa Y, Sakamoto M.

Lab Invest. 2015 Mar;95(3):308-19. doi: 10.1038/labinvest.2014.166. Epub 2015 Jan 19.

17.

Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT.

Flores LG, Bertolini S, Yeh HH, Young D, Mukhopadhyay U, Pal A, Ying Y, Volgin A, Shavrin A, Soghomonyan S, Tong W, Bornmann W, Alauddin MM, Logsdon C, Gelovani JG.

PLoS One. 2009 Nov 24;4(11):e7977. doi: 10.1371/journal.pone.0007977.

18.

Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer.

Yao J, Zhang LL, Huang XM, Li WY, Gao SG.

World J Gastroenterol. 2017 Jun 7;23(21):3907-3914. doi: 10.3748/wjg.v23.i21.3907.

19.

Study on the relationship between CXCR4 expression and perineural invasion in pancreatic cancer.

Jiang YM, Li G, Sun BC, Zhao XL, Zhou ZK.

Asian Pac J Cancer Prev. 2014;15(12):4893-6.

20.

Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.

Yan TT, Fu XL, Li J, Bian YN, Liu DJ, Hua R, Ren LL, Li CT, Sun YW, Chen HY, Fang JY, Hong J.

Oncotarget. 2015 Nov 10;6(35):37028-42. doi: 10.18632/oncotarget.5939.

Supplemental Content

Support Center